News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Elias Karam: New Treatments for HCC Were Presented at ESMO GI 2025
Elias Karam/LinkedIn
Jul 4, 2025, 15:43

Elias Karam: New Treatments for HCC Were Presented at ESMO GI 2025

Elias Karam, Hematology-Medical Oncology Fellow at Gustave Roussy, shared a post on LinkedIn:

“Live from ESMO GI 2025 Barcelona

New HCC treatments:

  • Novel checkpoints (TIGIT, TIM-3)
  • CAR-T, TCR, bispecific engagers
  • Targeting β-catenin, HDAC, oncolytic viruses

Focus: 5-year survival, cure, QoL.”

Elias Karam: New Treatments for HCC Were Presented at ESMO GI 2025

More posts featuring ESMOGI25 

 

cancer Elias Karam ESMOGI25 HCC liver cancer OncoDaily Oncology
Special Coverage
Blog
Jul 27, 2025, 18:45
Thanks for Showing Up, Sharing Your Work, and Believing in Collaboration at KCRS25 - KidneyCAN
Blog
Jul 27, 2025, 18:34
Hamza Hashmi: Sharing Ideas, Research, and Debates on Myeloma at the MM Sparks Event in Merida
Blog
Jul 27, 2025, 18:26
Cathy Eng: Always a Pleasure to Listen to Kristen Ciombor Give a Lecture about Immunotherapy in MSI-S CRC
Blog
Jul 27, 2025, 17:40
Aladina Foundation's Psychooncologists Offer a Consultation Outside the Hospital for Free
Opinion
Jul 27, 2025, 17:27
Ian Davis: Why Chemotherapy Has Not Stopped Working in Metastatic Prostate Cancer for More than 20 Years
Blog
Jul 27, 2025, 16:53
Luis E. Raez: The FLASCO “Breaking Barriers” Conference Returns This November
Career
Jul 27, 2025, 16:20
Justin Perry Has Been Promoted to Associate Member at Memorial Sloan Kettering Cancer Center
Blog
Jul 27, 2025, 16:04
Helena Linardou: ESMO Virtual Journal Club – July 2025 Edition
Blog
Jul 27, 2025, 15:57
A Deep Dive Into the Most Important Lung Cancer Trials Presented at ASCO25 - IASLC
Blog
Jul 27, 2025, 15:38
Sergio Cifuentes Canaval: First Meeting of Young Oncologists Group
Science
Jul 27, 2025, 15:14
Talha Badar: PII Trial of CPX-351 and Venetoclax
Insight
Jul 27, 2025, 15:13
Potential Breakthrough for Glioma: Servier’s Therapy Nears EMA Approval - Servier Pharmaceuticals